PreveCeutical Medical Inc. PREV
CNSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -481.80K | -968.20K | -1.11M | -2.21M | -1.83M |
| Total Depreciation and Amortization | 11.20K | 11.10K | 10.30K | 9.50K | 8.80K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -1.12M | -840.30K | -825.00K | 752.60K | 728.60K |
| Change in Net Operating Assets | 431.70K | 431.60K | 681.30K | 540.10K | 484.00K |
| Cash from Operations | -1.16M | -1.37M | -1.24M | -902.90K | -606.90K |
| Capital Expenditure | 0.00 | -2.10K | -2.10K | -2.60K | -2.70K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 41.40K | 41.70K | 1.70K | -100.00 | -39.70K |
| Cash from Investing | 41.40K | 39.60K | -400.00 | -2.70K | -42.40K |
| Total Debt Issued | 71.90K | 12.50K | 70.90K | 83.20K | 106.00K |
| Total Debt Repaid | -105.40K | -172.70K | -172.70K | -99.50K | -69.80K |
| Issuance of Common Stock | 1.60M | 2.01M | 1.78M | 1.41M | 872.40K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1.14M | 1.34M | 1.21M | 1.00M | 654.00K |
| Foreign Exchange rate Adjustments | 4.60K | 800.00 | -3.30K | -20.30K | -700.00 |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 23.70K | 13.60K | -33.10K | 76.00K | 3.80K |